Share

Updates matching "Access to Health Care"

July 28, 2017

The U.S. Senate fell short of the votes needed to pass legislation that would have repealed parts of the current health care law, likely resulting in millions losing health insurance and patients paying more for less coverage.

July 27, 2017
National

The U.S. Senate is reported to be considering a “skinny” health care repeal bill that according to earlier Congressional Budget Office estimates of similar repeal could cause 15 million Americans to lose their insurance coverage over the next ten years

July 24, 2017
National

A new report shows that while opportunities for coverage have improved, cancer patients still struggle with significant financial challenges in affording their treatment despite substantial reductions in out-of-pocket costs and patient protections under current law.

July 19, 2017
National

ACS CAN joined 12 other major patient advocacy groups in asking all Senators to vote no on repeal.

July 19, 2017
National

Any attempt to repeal the ACA without replacing it with equal or better coverage will leave our health care system in shambles. If the existing law is abolished, 32 million Americans could lose their insurance coverage in the next decade. This approach is completely unacceptable for the patients we represent.

July 17, 2017
California

Sacramento, CA – The voices of cancer patients, survivors and their loved ones are making a difference at the Capitol as evidenced by the critically-important cancer-fighting policies that passed the Legislature in 2016. The advocacy affiliate for the American Cancer Society, the American Cancer Society Cancer Action Network (ACS CAN),

July 14, 2017
National

The latest version of the bill released is shockingly worse than earlier drafts and could be devastating to cancer patients and survivors.

July 13, 2017
Kansas

ACS CAN Kansas staff set out on a #RoadtriptoPalco to attend Sen. Moran's town hall and to ask him to protect quality, affordable healthcare.

July 12, 2017
National

The House advanced legislation to reauthorize and expand the FDA's user fee programs that maintain a strong partnership between the FDA and industry, with the goal of bringing pharmaceutical drugs and devices to the market, and making them accessible to patients, as expeditiously as possible.